AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Dr. Martens PLC

Board/Management Information Mar 22, 2022

5055_dirs_2022-03-22_eb5cd195-9c40-4d7c-9d8e-7cd1bee0bdcb.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5760F

Dr. Martens PLC

22 March 2022

22 March 2022

Dr. Martens plc

Director Declaration

Pursuant to Listing Rule 9.6.14(2), Dr. Martens plc confirms that Lynne Weedall will be appointed to the Board of Softcat plc as a Non-Executive Director with effect from 3 May 2022.

ENDS

Enquiries:

Paul Rolling, Assistant Company Secretary       +447584243562

About Dr. Martens plc:

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

The Company successfully listed on the main market of the London Stock Exchange in January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNDLLBLLXLZBBB

Talk to a Data Expert

Have a question? We'll get back to you promptly.